User:Libby EMAcomm/Working page 2019

Here are my edits, please comment:

Fenspiride: Added link to EMA page on withdrawal of fenspiride medicines

Fenspiride: 04/10 Edited EMA reference to remove web editor's name

Omega-3 fatty acid: 04/10 Added summary of EMA review

Ulipristal acetate: 04/10 updated with final outcome of EMA review

Radium-223: 04/10 updated with summary of EMA Art 20 review

Hydroxyethyl starch: 04/10 updated with final outcome of Art 107i review

Daclizumab: 04/10 updated with information that the medicine was withdrawn

Dolutegravir: 16/10 updated with sentence on pregnancy contraindication in EU

Valproate: 16/10 added outcome of EMA 2018 review in pregnancy section

Quinolone antibiotic: 02/12 added outcome of EMA review in Other section

Cinoxacin: 02/12 added info that the MA suspended

Flumequine: 02/12 added info that the MA suspended

Nalidixic acid: 02/12 added info that the MA suspended

Pipemidic acid: 02/12 added info that the MA suspended

SGLT2 inhibitor: 02/12 /* Adverse effects */ Published outcome of EU review on risk of lower limb amputation